David Asboe

6.1k total citations
67 papers, 1.6k citations indexed

About

David Asboe is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, David Asboe has authored 67 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Infectious Diseases, 25 papers in Virology and 25 papers in Epidemiology. Recurrent topics in David Asboe's work include HIV/AIDS Research and Interventions (36 papers), HIV Research and Treatment (24 papers) and HIV/AIDS drug development and treatment (23 papers). David Asboe is often cited by papers focused on HIV/AIDS Research and Interventions (36 papers), HIV Research and Treatment (24 papers) and HIV/AIDS drug development and treatment (23 papers). David Asboe collaborates with scholars based in United Kingdom, Belgium and Italy. David Asboe's co-authors include Sundhiya Mandalia, Brian Gazzard, Alison Rodger, Valentina Cambiano, Richard Gilson, Nneka Nwokolo, Janey Sewell, Andrew Phillips, Amanda Clarke and Andrew Speakman and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Allergy and Clinical Immunology.

In The Last Decade

David Asboe

66 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Asboe United Kingdom 23 1.1k 731 458 235 184 67 1.6k
Víctoria Hernando Spain 19 1.1k 1.0× 804 1.1× 379 0.8× 155 0.7× 278 1.5× 55 1.5k
Rana Chakraborty United States 27 1.4k 1.3× 824 1.1× 441 1.0× 139 0.6× 116 0.6× 98 2.6k
Mauro Zaccarelli Italy 25 1.2k 1.2× 498 0.7× 953 2.1× 218 0.9× 87 0.5× 91 1.7k
Esther Robison United States 19 877 0.8× 421 0.6× 426 0.9× 578 2.5× 133 0.7× 32 1.6k
Lorie Benning United States 22 936 0.9× 579 0.8× 493 1.1× 858 3.7× 82 0.4× 44 1.9k
Erik J.C. van Ameijden Netherlands 28 893 0.8× 1.6k 2.2× 250 0.5× 92 0.4× 192 1.0× 68 2.2k
Réjean Thomas Canada 22 1.2k 1.1× 656 0.9× 929 2.0× 170 0.7× 210 1.1× 84 1.8k
Seble Kassaye United States 24 1.3k 1.3× 675 0.9× 505 1.1× 466 2.0× 202 1.1× 135 2.1k
Lois Eldred United States 19 1.2k 1.1× 904 1.2× 330 0.7× 175 0.7× 138 0.8× 34 1.6k
Laura W. Cheever United States 20 1.5k 1.5× 1.2k 1.7× 463 1.0× 239 1.0× 229 1.2× 52 2.2k

Countries citing papers authored by David Asboe

Since Specialization
Citations

This map shows the geographic impact of David Asboe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Asboe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Asboe more than expected).

Fields of papers citing papers by David Asboe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Asboe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Asboe. The network helps show where David Asboe may publish in the future.

Co-authorship network of co-authors of David Asboe

This figure shows the co-authorship network connecting the top 25 collaborators of David Asboe. A scholar is included among the top collaborators of David Asboe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Asboe. David Asboe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hammond, Robert, Valentina Cambiano, Fiona Lampe, et al.. (2023). Predictors of starting and stopping chemsex in men who have sex with men in England: findings from the AURAH2 prospective study. Sexually Transmitted Infections. 99(7). 474–481. 5 indexed citations
2.
Brown, Alison, Sara Croxford, Sophie Nash, et al.. (2021). COVID‐19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID‐19 pandemic in England. HIV Medicine. 23(1). 90–102. 13 indexed citations
3.
4.
Sewell, Janey, Valentina Cambiano, Andrew Speakman, et al.. (2019). Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: Findings from the AURAH2 study. International Journal of Drug Policy. 68. 54–61. 77 indexed citations
5.
Sewell, Janey, Ada Miltz, Fiona Lampe, et al.. (2017). Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics. International Journal of Drug Policy. 43. 33–43. 166 indexed citations
6.
Sewell, Janey, Andrew Speakman, Andrew Phillips, et al.. (2016). Attitudes to and Understanding of Risk of Acquisition of HIV Over Time: Design and Methods for an Internet-based Prospective Cohort Study Among UK Men Who Have Sex With Men (the AURAH2 Study). JMIR Research Protocols. 5(2). e128–e128. 7 indexed citations
7.
8.
Purdie, Karin J., Maurits N.C. de Koning, Koen D. Quint, et al.. (2016). HLA Immunogenotype Determines Persistent Human Papillomavirus Virus Infection in HIV-Infected Patients Receiving Antiretroviral Treatment. The Journal of Infectious Diseases. 213(11). 1717–1724. 8 indexed citations
9.
Mbisa, Jean L., Esther Fearnhill, David Dunn, et al.. (2015). Evidence of Self-Sustaining Drug Resistant HIV-1 Lineages Among Untreated Patients in the United Kingdom. Clinical Infectious Diseases. 61(5). 829–836. 28 indexed citations
10.
Jones, Rachael, et al.. (2014). Transmitted antiretroviral drug resistance in treatment naïve HIV‐infected persons in London in 2011 to 2013. Journal of the International AIDS Society. 17(4S3). 19747–19747. 5 indexed citations
11.
Bradshaw, Daniel, D.J. Hughes, Λεωνιδία Λεωνίδου, et al.. (2013). Screening for HIV-related neurocognitive impairment in clinical practice: Challenges and opportunities. AIDS Care. 26(2). 160–168. 13 indexed citations
12.
Clark, Sally A., Emma Page, Tom Ford, et al.. (2011). Reduced TH1/TH17 CD4 T-cell numbers are associated with impaired purified protein derivative–specific cytokine responses in patients with HIV-1 infection. Journal of Allergy and Clinical Immunology. 128(4). 838–846.e5. 12 indexed citations
13.
Scott, Christopher, et al.. (2010). Unselected hepatitis C screening of men who have sex with men attending sexual health clinics. Journal of Infection. 60(5). 351–353. 23 indexed citations
14.
Coyne, Katherine, et al.. (2009). The International Index of Erectile Function: Development of an Adapted Tool for Use in HIV-Positive Men Who Have Sex with Men. The Journal of Sexual Medicine. 7(2_Part_1). 769–774. 65 indexed citations
15.
Stelly, David M., et al.. (2009). Positive and negative drug selection pressures on the N348I connection domain mutation: new insights from in vivo data. UCL Discovery (University College London). 1 indexed citations
16.
Asboe, David, et al.. (2007). A virological benefit from an induction/maintenance strategy: the Forte trial.. PubMed. 12(1). 47–54. 9 indexed citations
17.
Gilleece, Yvonne, David Asboe, Mark Atkins, et al.. (2005). Transmission of Hepatitis C Virus Among HIV-Positive Homosexual Men and Response to a 24-Week Course of Pegylated Interferon and Ribavirin. JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(1). 41–46. 100 indexed citations
18.
Hawkins, David, David Asboe, K. L. Barlow, & B.G. Evans. (2001). Seroconversion to HIV-1 Following a Needlestick Injury Despite Combination Post-exposure Prophylaxis. Journal of Infection. 43(1). 12–15. 23 indexed citations
19.
Sullivan, Ann, Mark Nelson, Andrew J Shaw, et al.. (2000). Efficacy of a Nelfinavir- and Nevirapine-Containing Salvage Regimen. HIV Clinical Trials. 1(1). 7–12. 7 indexed citations
20.
Holdsworth, Gillian, et al.. (1999). Controlled management of public relations following a public health incident. Journal of Public Health. 21(3). 251–254. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Víctoria Hernando Breakdown of academic impact, for papers by Rana Chakraborty Breakdown of academic impact, for papers by Mauro Zaccarelli Breakdown of academic impact, for papers by Esther Robison Breakdown of academic impact, for papers by Lorie Benning Breakdown of academic impact, for papers by Erik J.C. van Ameijden Breakdown of academic impact, for papers by Réjean Thomas Breakdown of academic impact, for papers by Seble Kassaye Breakdown of academic impact, for papers by Lois Eldred Breakdown of academic impact, for papers by Laura W. Cheever
Rankless by CCL
2026